Literature DB >> 22813799

Formation of duodenal atresias in fibroblast growth factor receptor 2IIIb-/- mouse embryos occurs in the absence of an endodermal plug.

Robert A Botham1, Marta Franco, Amy L Reeder, Anastasia Lopukhin, Kohei Shiota, Shigehito Yamada, Peter F Nichol.   

Abstract

PURPOSE: Duodenal atresia in humans has been hypothesized to arise from a failure of the duodenal lumen to recanalize after formation of an endodermal plug. Recently, mutations in the fibroblast growth factor receptor 2 gene (Fgfr2IIIb) have been shown to cause atretic defects of the duodenum in mice. However, work in rats suggests that murine species do not form an endodermal plug during normal duodenal development. These lines of data led us to hypothesize that mice are able to form a duodenal atresia in the absence of an endodermal plug. To test this hypothesis, we examined duodenal development in wild-type and Fgfr2IIIb-/- embryos.
METHODS: Paraffin sections were generated for H&E, E-cadherin, or terminal deoxynucleotidyl transferase-mediated X-dUTP nick end labeling staining from Fgfr2IIIb-/- and wild-type embryos between embryonic days (E) 10.5 and E14.5. Sections were photographed and reconstructed into 3-dimensional display using Adobe Photoshop and Amira Visage software.
RESULTS: Normal mouse duodenum does not form an endodermal plug, although a plug does form in the pyloric region of the stomach at E14.5. Fgfr2IIIb-/- embryos experience significant apoptosis in the duodenal region at E10.5, followed by the disappearance of the endoderm in the atretic precursor by E11.5. Thereafter, the mesoderm of the atretic precursor involutes over the next 2 days in the absence of further apoptosis. Interestingly, an endodermal plug was not observed at any point during the formation of a duodenal atresia.
CONCLUSIONS: These results suggest that duodenal atresia in the Fgfr2IIIb-/- model does not arise from persistence of an epithelial plug. Rather it appears to result from the loss of the endoderm because of apoptosis very early in development.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22813799      PMCID: PMC3401378          DOI: 10.1016/j.jpedsurg.2012.02.001

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Mosaic Cre-mediated recombination in pancreas using the pdx-1 enhancer/promoter.

Authors:  M Gannon; P L Herrera; C V Wright
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Graphic and movie illustrations of human prenatal development and their application to embryological education based on the human embryo specimens in the Kyoto collection.

Authors:  Shigehito Yamada; Chigako Uwabe; Tomoko Nakatsu-Komatsu; Yutaka Minekura; Masaji Iwakura; Tamaki Motoki; Kazuhiko Nishimiya; Masaaki Iiyama; Koh Kakusho; Michihiko Minoh; Shinobu Mizuta; Tetsuya Matsuda; Yoshimasa Matsuda; Tomoyuki Haishi; Katsumi Kose; Shingo Fujii; Kohei Shiota
Journal:  Dev Dyn       Date:  2006-02       Impact factor: 3.780

3.  The fibroblast growth factor pathway serves a regulatory role in proliferation and apoptosis in the pathogenesis of intestinal atresia.

Authors:  Timothy J Fairbanks; Frederic G Sala; Robert Kanard; Jennifer L Curtis; Pierre M Del Moral; Stijn De Langhe; David Warburton; Kathryn D Anderson; Saverio Bellusci; R Cartland Burns
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

4.  A more efficient method to generate null mutants using Hprt-Cre with floxed alleles.

Authors:  Peter F Nichol; Robert Botham; Yukio Saijoh; Amy L Reeder; Krzyztoff M Zaremba
Journal:  J Pediatr Surg       Date:  2011-09       Impact factor: 2.545

5.  The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development.

Authors:  Richard Grose; Vera Fantl; Sabine Werner; Athina-Myrto Chioni; Monika Jarosz; Robert Rudling; Barbara Cross; Ian R Hart; Clive Dickson
Journal:  EMBO J       Date:  2007-02-15       Impact factor: 11.598

6.  Colonic atresia without mesenteric vascular occlusion. The role of the fibroblast growth factor 10 signaling pathway.

Authors:  Timothy J Fairbanks; Robert C Kanard; Pierre M Del Moral; Fred G Sala; Stijn P De Langhe; Chrissy A Lopez; Jacqueline M Veltmaat; David Warburton; Kathryn D Anderson; Saverio Bellusci; R Cartland Burns
Journal:  J Pediatr Surg       Date:  2005-02       Impact factor: 2.545

7.  Fibroblast growth factor receptor 2 IIIb invalidation--a potential cause of familial duodenal atresia.

Authors:  Timothy J Fairbanks; Robert Kanard; Pierre M Del Moral; Frederic G Sala; Stijn De Langhe; David Warburton; Kathryn D Anderson; Saverio Bellusci; R Cartland Burns
Journal:  J Pediatr Surg       Date:  2004-06       Impact factor: 2.545

8.  Requirement for fibroblast growth factor 10 or fibroblast growth factor receptor 2-IIIb signaling for cecal development in mouse.

Authors:  R C Burns; T J Fairbanks; F Sala; S De Langhe; A Mailleux; J P Thiery; C Dickson; N Itoh; D Warburton; K D Anderson; S Bellusci
Journal:  Dev Biol       Date:  2004-01-01       Impact factor: 3.582

9.  An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis.

Authors:  L De Moerlooze; B Spencer-Dene; J M Revest; M Hajihosseini; I Rosewell; C Dickson
Journal:  Development       Date:  2000-02       Impact factor: 6.868

Review 10.  Fibroblast growth factors.

Authors:  D M Ornitz; N Itoh
Journal:  Genome Biol       Date:  2001-03-09       Impact factor: 13.583

View more
  6 in total

1.  Lack of discreet colocalization of epithelial apoptosis to the atretic precursor in the colon of the Fibroblast growth factor receptor 2IIIb mouse and staining consistent with cellular movement suggest a revised model of atresia formation.

Authors:  Anna Kowalkowski; Krzysztof M Zaremba; Andrew P Rogers; Olivia R Hoffman; Anne E Turco; Peter F Nichol
Journal:  Dev Dyn       Date:  2020-03-10       Impact factor: 3.780

2.  Haploinsufficiency of retinaldehyde dehydrogenase 2 decreases the severity and incidence of duodenal atresia in the fibroblast growth factor receptor 2IIIb-/- mouse model.

Authors:  Amy L Reeder; Robert A Botham; Krzysztof M Zaremba; Peter F Nichol
Journal:  Surgery       Date:  2012-10       Impact factor: 3.982

3.  Maternal hyperthyroidism increases the prevalence of foregut atresias in fetal rats exposed to adriamycin.

Authors:  Ana Catarina Fragoso; Leopoldo Martinez; José Estevão-Costa; Juan A Tovar
Journal:  Pediatr Surg Int       Date:  2014-02       Impact factor: 1.827

4.  Formation of intestinal atresias in the Fgfr2IIIb-/- mice is not associated with defects in notochord development or alterations in Shh expression.

Authors:  Amy L Reeder; Robert A Botham; Marta Franco; Krzysztof M Zaremba; Peter F Nichol
Journal:  J Surg Res       Date:  2012-04-29       Impact factor: 2.192

5.  FGF10 and the Mystery of Duodenal Atresia in Humans.

Authors:  Warwick J Teague; Matthew L M Jones; Leanne Hawkey; Ian M Smyth; Angelique Catubig; Sebastian K King; Gulcan Sarila; Ruili Li; John M Hutson
Journal:  Front Genet       Date:  2018-11-09       Impact factor: 4.599

Review 6.  The Role of Fibroblast Growth Factor 10 Signaling in Duodenal Atresia.

Authors:  Matthew L M Jones; Gulcan Sarila; Pierre Chapuis; John M Hutson; Sebastian K King; Warwick J Teague
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.